Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Douglas Emmett reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Douglas Emmett announced earnings per share of $0.51 on revenue of $253.7M. Analysts polled by Investing.com EPS of $0.14 on revenue of $251.96M.
Douglas Emmett 's are down 12% and is trading at $17.27 , still down 53.29% from its 52 week high of $36.97 set on Friday, January 7, 2022.
Douglas Emmett follows other major Real Estate sector earnings this month
Douglas Emmett's report follows an earnings beat by Prologis on Wednesday, October 19, 2022, who reported EPS of $1.36 on revenue of $1.75B, EPS of $1.34 on revenue of $1.2B.
American Tower had beat expectations on Thursday, October 27, 2022 with third quarter EPS of $1.8 on revenue of $2.67B, for EPS of $1.13 on revenue of $2.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar